Firefly Inks Latest Commercial Agreement for Use of Its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

Firefly Neuroscience, Inc. highlighted its ongoing collaboration with Prof. Dr. med. Christian Schaaf on a groundbreaking study investigating the neurophysiological impact of 15q13.3 copy number variants.